Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Insulin glulisine bulk supplier for pharma manufacturers

Insulin Glulisine 100 IU/mL Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 100 IU/mL

Reference Brands: Apidra (USA/EU)

Category: Diabetes

Insulin Glulisine is a rapid-acting insulin analog used to manage blood glucose levels in patients with diabetes mellitus. It works by replacing or supplementing endogenous insulin, facilitating glucose uptake into cells, and reducing blood sugar levels after meals. It is administered via subcutaneous injection and may also be given intravenously in hospital settings for rapid glycemic control.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Insulin Glulisine — third party manufacturing & bulk supply

Insulin Glulisine 100 IU/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Insulin Glulisine is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Insulin Glulisine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Insulin Glulisine →
Back to Listing

Frequently Asked Questions

Insulin glulisine is listed as injection (prefilled syringe) in 100 IU/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Insulin glulisine is referenced against Apidra (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Albiglutide

Strength:
30mg, 50mg

Form: injection (prefilled syringe)

Reference Brands: Tanzeum (USA), Eperzan (EU/UK)

View Details
Ertugliflozin

Strength:
5 mg, 15 mg

Form: Tablets

Reference Brands: Steglatro (USA/EU)

View Details
Exenatide

Strength:
5 mcg/1.2 mL, 10 mcg/2.4 mL

Form: injection (prefilled syringe)

Reference Brands: Byetta (USA/EU), Bydureon (USA)

View Details
Alogliptin Tablet

Strength:
6.25 mg, 12.5 mg, 25 mg

Form: Tablet

Reference Brands: Nesina (USA/EU), Kazano (USA), Vipidia (EU)

View Details
Glibenclamide Tablets

Strength:
1.25 mg, 2.5 mg, 5 mg

Form: Tablets

Reference Brands: Diabeta (USA), Euglucon (EU)

View Details
Glibenclamide And Metformin Oral Tablets (Immediate-Release)

Strength:
Glibenclamide 2.5 mg + Metformin 500 mg; Glibenclamide 5 mg + Metformin 500 mg

Form: Tablets IR

Reference Brands: Glucovance®,®, Euglucon-M®, Glyburid-M®(EU & US)

View Details
Gliclazide + Metformin Tablets(Ir)

Strength:
Gliclazide 80 mg + Metformin 500 mg

Form: Tablets(IR)

Reference Brands: Glizid-M, Glyciphage-G(US & EU)

View Details
Gliclazide + Metformin Tablets(Er)

Strength:
Gliclazide 30 mg/60 mg + Metformin 500/1000 mg

Form: Tablets(ER)

Reference Brands: Glizid-M XR(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.